BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 14963480)

  • 1. Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole.
    Rhoden EL; Morgentaler A
    Int J Impot Res; 2004 Feb; 16(1):95-7. PubMed ID: 14963480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels.
    Dougherty RH; Rohrer JL; Hayden D; Rubin SD; Leder BZ
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):228-35. PubMed ID: 15670201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pubertal gynecomastia with the specific aromatase inhibitor anastrozole.
    Riepe FG; Baus I; Wiest S; Krone N; Sippell WG; Partsch CJ
    Horm Res; 2004; 62(3):113-8. PubMed ID: 15273427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
    Leder BZ; Rohrer JL; Rubin SD; Gallo J; Longcope C
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1174-80. PubMed ID: 15001605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
    Boccardo F; Rubagotti A; Conti G; Potenzoni D; Manganelli A; Del Monaco D
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):415-20. PubMed ID: 15838655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of anastrozole and testosterone versus placebo and testosterone for treatment of sexual dysfunction in men with epilepsy and hypogonadism.
    Herzog AG; Farina EL; Drislane FW; Schomer DL; Smithson SD; Fowler KM; Dworetzky BA; Bromfield EB
    Epilepsy Behav; 2010 Feb; 17(2):264-71. PubMed ID: 20096638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor.
    Shippen ER; West WJ
    Fertil Steril; 2004 May; 81(5):1395-8. PubMed ID: 15136110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.
    Leder BZ; Finkelstein JS
    Osteoporos Int; 2005 Dec; 16(12):1487-94. PubMed ID: 15856361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coadministration of anastrozole sustains therapeutic testosterone levels in hypogonadal men undergoing testosterone pellet insertion.
    Mechlin CW; Frankel J; McCullough A
    J Sex Med; 2014 Jan; 11(1):254-61. PubMed ID: 24119010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High estrogen in men after injectable testosterone therapy: the low T experience.
    Tan RS; Cook KR; Reilly WG
    Am J Mens Health; 2015 May; 9(3):229-34. PubMed ID: 24928451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Words of wisdom. Re: Coadministration of anastrozole sustains therapeutic testosterone levels in hypogonadal men undergoing testosterone pellet insertion.
    Bennett NE
    Eur Urol; 2014 Dec; 66(6):1188-9. PubMed ID: 25587593
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of aromatization in testosterone supplementation: effects on cognition in older men.
    Cherrier MM; Matsumoto AM; Amory JK; Ahmed S; Bremner W; Peskind ER; Raskind MA; Johnson M; Craft S
    Neurology; 2005 Jan; 64(2):290-6. PubMed ID: 15668427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibition for the treatment of idiopathic hypogonadotropic hypogonadism in men with premature ejaculation.
    Holbrook JM; Cohen PG
    South Med J; 2003 Jun; 96(6):544-7. PubMed ID: 12938779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythema multiforme after radiotherapy with aromatase inhibitor administration in breast-conservation treatment for breast cancer.
    Nakatani K; Matsumoto M; Ue H; Nishioka A; Tanaka Y; Kodama H; Sasaguri S; Ogawa Y
    Breast Cancer; 2008; 15(4):321-3. PubMed ID: 18278432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study.
    Hefler LA; Grimm C; van Trotsenburg M; Nagele F
    Fertil Steril; 2005 Oct; 84(4):1033-6. PubMed ID: 16213868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anastrozole, an aromatase inhibitor, and medroxyprogesterone acetate therapy in premenopausal obese women with endometrial cancer: a report of two cases successfully treated without hysterectomy.
    Burnett AF; Bahador A; Amezcua C
    Gynecol Oncol; 2004 Sep; 94(3):832-4. PubMed ID: 15350383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism.
    de Boer H; Verschoor L; Ruinemans-Koerts J; Jansen M
    Diabetes Obes Metab; 2005 May; 7(3):211-5. PubMed ID: 15811136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of the aromatase inhibitor anastrozole on bone metabolism and cardiovascular risk indices in ovariectomized, androgen-treated female-to-male transsexuals.
    Bunck MC; Toorians AW; Lips P; Gooren LJ
    Eur J Endocrinol; 2006 Apr; 154(4):569-75. PubMed ID: 16556720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anastrozole improved testosterone-induced impairment acquisition of spatial learning and memory in the hippocampal CA1 region in adult male rats.
    Moradpour F; Naghdi N; Fathollahi Y
    Behav Brain Res; 2006 Dec; 175(2):223-32. PubMed ID: 17018237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.